2-165874238-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024753.5(TTC21B):​c.*517G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 151,938 control chromosomes in the GnomAD database, including 2,345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2345 hom., cov: 32)
Exomes 𝑓: 0.16 ( 13 hom. )
Failed GnomAD Quality Control

Consequence

TTC21B
NM_024753.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.56

Publications

2 publications found
Variant links:
Genes affected
TTC21B (HGNC:25660): (tetratricopeptide repeat domain 21B) This gene encodes a member of TTC21 family, containing several tetratricopeptide repeat (TPR) domains. This protein is localized to the cilium axoneme, and may play a role in retrograde intraflagellar transport in cilia. Mutations in this gene are associated with various ciliopathies, nephronophthisis 12, and asphyxiating thoracic dystrophy 4. [provided by RefSeq, Oct 2011]
TTC21B Gene-Disease associations (from GenCC):
  • nephronophthisis 12
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • asphyxiating thoracic dystrophy 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 2-165874238-C-T is Benign according to our data. Variant chr2-165874238-C-T is described in ClinVar as [Benign]. Clinvar id is 331811.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC21BNM_024753.5 linkc.*517G>A 3_prime_UTR_variant Exon 29 of 29 ENST00000243344.8 NP_079029.3
TTC21BXM_047445870.1 linkc.*517G>A 3_prime_UTR_variant Exon 25 of 25 XP_047301826.1
TTC21BXM_011511871.4 linkc.*517G>A 3_prime_UTR_variant Exon 24 of 24 XP_011510173.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC21BENST00000243344.8 linkc.*517G>A 3_prime_UTR_variant Exon 29 of 29 1 NM_024753.5 ENSP00000243344.7 Q7Z4L5-1

Frequencies

GnomAD3 genomes
AF:
0.172
AC:
26112
AN:
151820
Hom.:
2344
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.241
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.242
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.329
Gnomad NFE
AF:
0.182
Gnomad OTH
AF:
0.209
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.158
AC:
133
AN:
842
Hom.:
13
Cov.:
0
AF XY:
0.167
AC XY:
95
AN XY:
570
show subpopulations
African (AFR)
AF:
0.167
AC:
1
AN:
6
American (AMR)
AF:
0.0667
AC:
2
AN:
30
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
2
AN:
4
East Asian (EAS)
AF:
0.147
AC:
5
AN:
34
South Asian (SAS)
AF:
0.107
AC:
3
AN:
28
European-Finnish (FIN)
AF:
0.167
AC:
1
AN:
6
Middle Eastern (MID)
AF:
0.500
AC:
2
AN:
4
European-Non Finnish (NFE)
AF:
0.160
AC:
113
AN:
706
Other (OTH)
AF:
0.167
AC:
4
AN:
24
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.172
AC:
26128
AN:
151938
Hom.:
2345
Cov.:
32
AF XY:
0.172
AC XY:
12749
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.138
AC:
5739
AN:
41484
American (AMR)
AF:
0.186
AC:
2829
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
944
AN:
3464
East Asian (EAS)
AF:
0.144
AC:
740
AN:
5142
South Asian (SAS)
AF:
0.241
AC:
1163
AN:
4822
European-Finnish (FIN)
AF:
0.150
AC:
1580
AN:
10534
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.182
AC:
12375
AN:
67938
Other (OTH)
AF:
0.208
AC:
440
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1109
2218
3326
4435
5544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.172
Hom.:
275
Bravo
AF:
0.175
Asia WGS
AF:
0.185
AC:
643
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Asphyxiating thoracic dystrophy 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nephronophthisis 12 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.34
DANN
Benign
0.73
PhyloP100
-3.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77199262; hg19: chr2-166730748; API